BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38697967)

  • 1. A novel long non-coding RNA MIR4500HG003 promotes tumor metastasis through miR-483-3p-MMP9 axis in triple-negative breast cancer.
    Lin WD; Chang CH; Pan JK; Lin FC; Chen YC; Chen YJ; Wang PS; Hong WQ; Chen SY; Lin CH; Kuo YL; Chung WP; Cheng HC; Hsiao M; Yang CN; Lu PJ
    Cell Death Dis; 2024 May; 15(5):310. PubMed ID: 38697967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel long non-coding RNA linc-ZNF469-3 promotes lung metastasis through miR-574-5p-ZEB1 axis in triple negative breast cancer.
    Wang PS; Chou CH; Lin CH; Yao YC; Cheng HC; Li HY; Chuang YC; Yang CN; Ger LP; Chen YC; Lin FC; Shen TL; Hsiao M; Lu PJ
    Oncogene; 2018 Aug; 37(34):4662-4678. PubMed ID: 29755127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNA GHET1 Promotes the Progression of Triple-Negative Breast Cancer
    Wang Y; Li C
    Comput Math Methods Med; 2022; 2022():8366569. PubMed ID: 35509860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA prostate cancer-associated transcript 18 upregulates activating transcription factor 7 to prevent metastasis of triple-negative breast cancer via sponging miR-103a-3p.
    Zhang J; Liu D; Deng G; Wang Q; Li L; Zhang J; Wu H
    Bioengineered; 2021 Dec; 12(2):12070-12086. PubMed ID: 34787047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA DANCR upregulation induced by TUFT1 promotes malignant progression in triple negative breast cancer via miR-874-3p-SOX2 axis.
    Wu G; Zhou H; Li D; Zhi Y; Liu Y; Li J; Wang F
    Exp Cell Res; 2020 Nov; 396(2):112331. PubMed ID: 33058834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel tumor suppressor ASMTL-AS1 regulates the miR-1228-3p/SOX17/β-catenin axis in triple-negative breast cancer.
    Sun J; Li X; Yu E; Liu J; Sun L; He Q; Lu Q
    Diagn Pathol; 2021 May; 16(1):45. PubMed ID: 34006305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
    Guo C; Zhang M; Jin X; Zhu C; Qian J; Tao M
    Cell Biochem Funct; 2024 Jun; 42(4):e4020. PubMed ID: 38702967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of hsa-miR-448.
    Bamodu OA; Huang WC; Lee WH; Wu A; Wang LS; Hsiao M; Yeh CT; Chao TY
    BMC Cancer; 2016 Feb; 16():160. PubMed ID: 26917489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
    Wang GP; Mou ZL; Xu YY; Liu GX; Wang DM; Zhang HP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7445-7456. PubMed ID: 31539132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA LUCAT1 facilitates tumorigenesis and metastasis of triple-negative breast cancer through modulating miR-5702.
    Mou E; Wang H
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31399501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA ST8SIA6-AS1 promotes cell proliferation and metastasis in triple-negative breast cancer by targeting miR-145-5p/CDCA3 to inactivate the p53/p21 signaling pathway.
    Qiao Y; Wang B; Yan Y; Niu L
    Environ Toxicol; 2022 Oct; 37(10):2398-2411. PubMed ID: 35730485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA AFAP1-AS1 promotes tumor progression and invasion by regulating the miR-2110/Sp1 axis in triple-negative breast cancer.
    Zhang X; Li F; Zhou Y; Mao F; Lin Y; Shen S; Li Y; Zhang S; Sun Q
    Cell Death Dis; 2021 Jun; 12(7):627. PubMed ID: 34145213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA SNHG3 promotes breast cancer cell proliferation and metastasis by binding to microRNA-154-3p and activating the notch signaling pathway.
    Jiang H; Li X; Wang W; Dong H
    BMC Cancer; 2020 Sep; 20(1):838. PubMed ID: 32883233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
    Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
    J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p.
    Jin L; Luo C; Wu X; Li M; Wu S; Feng Y
    Aging (Albany NY); 2021 Aug; 13(15):19306-19316. PubMed ID: 34375306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA LINC00885 upregulates NCK1 to promote cell viability and migration of triple-negative breast cancer cells through sponging miR-654-3p.
    He P; Liu Z; Qi J; Shan J; Sheng J
    Cancer Biomark; 2024; 39(1):63-78. PubMed ID: 37694355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells.
    Liang F; Fu X; Wang L
    J Cell Biochem; 2019 Oct; 120(10):18415-18424. PubMed ID: 31190375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis.
    Wang J; Li M; Han X; Wang H; Wang X; Ma G; Xia T; Wang S
    Cell Death Dis; 2020 Jul; 11(7):500. PubMed ID: 32620748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of long non-coding RNA TP73-AS1 suppresses triple negative breast cancer cell vasculogenic mimicry by targeting miR-490-3p/TWIST1 axis.
    Tao W; Sun W; Zhu H; Zhang J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):629-634. PubMed ID: 30193732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.
    Du C; Wang Y; Zhang Y; Zhang J; Zhang L; Li J
    Cell Transplant; 2020; 29():963689720929983. PubMed ID: 32686982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.